Mainz Biomed BV (MYNZ)

Currency in USD
1.8400
-0.0200(-1.08%)
Closed·
After Hours
1.7600-0.0800(-4.35%)
·
MYNZ Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MYNZ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.80001.9100
52 wk Range
1.338119.0040
Key Statistics
Prev. Close
1.86
Open
1.89
Day's Range
1.8-1.91
52 wk Range
1.3381-19.004
Volume
49.27K
Average Volume (3m)
144.22K
1-Year Change
-86.71%
Book Value / Share
1.79
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MYNZ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
14.0000
Upside
+660.87%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Mainz Biomed BV News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Mainz Biomed BV Company Profile

Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.

Compare MYNZ to Peers and Sector

Metrics to compare
MYNZ
Peers
Sector
Relationship
P/E Ratio
−0.3x0.0x−0.5x
PEG Ratio
0.000.000.00
Price/Book
1.1x9.9x2.6x
Price / LTM Sales
7.2x9.7x3.2x
Upside (Analyst Target)
-66.7%42.0%
Fair Value Upside
Unlock12.6%6.6%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 14.0000
(+660.87% Upside)

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / -2.80
Revenue / Forecast
-- / 300.00K
EPS Revisions
Last 90 days

MYNZ Income Statement

People Also Watch

0.770
WINT
-5.52%
0.9555
GNS
-9.86%
16.75
SRPT
+5.81%
14.00
OSCR
+1.16%
2.530
RSLS
+8.58%

FAQ

What Stock Exchange Does Mainz Biomed BV Trade On?

Mainz Biomed BV is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Mainz Biomed BV?

The stock symbol for Mainz Biomed BV is "MYNZ."

What Is the Mainz Biomed BV Market Cap?

As of today, Mainz Biomed BV market cap is 6.40M.

What Is Mainz Biomed BV's Earnings Per Share (TTM)?

The Mainz Biomed BV EPS (TTM) is -22.36.

When Is the Next Mainz Biomed BV Earnings Date?

Mainz Biomed BV will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is MYNZ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Mainz Biomed BV Stock Split?

Mainz Biomed BV has split 1 times.

How Many Employees Does Mainz Biomed BV Have?

Mainz Biomed BV has 23 employees.

What is the current trading status of Mainz Biomed BV (MYNZ)?

As of 30 Jul 2025, Mainz Biomed BV (MYNZ) is trading at a price of 1.84, with a previous close of 1.86. The stock has fluctuated within a day range of 1.80 to 1.91, while its 52-week range spans from 1.34 to 19.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.